Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KRMD
KRMD logo

KRMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy KORU Medical Systems Inc (KRMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.460
1 Day change
-2.83%
52 Week Range
6.610
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

KRMD is not a strong buy right now for a beginner long-term investor with $50,000-$100,000. The stock has some short-term technical strength, but the lack of news, no strong proprietary buy signal, neutral insider and hedge fund activity, and no financial snapshot makes the long-term case weak. Given the investor profile and impatience for waiting on a better entry, the best call is to hold and wait rather than buy immediately.

Technical Analysis

KRMD is trading near short-term resistance, with price at 4.485 versus pivot 4.194 and R1 at 4.481. MACD histogram is positive and expanding, which supports near-term momentum. However, RSI_6 is 69.525, suggesting the stock is getting stretched and may be near overbought conditions. Moving averages are converging, which usually signals an unclear trend rather than a strong sustained breakout. The nearby resistance at 4.659 may cap upside unless momentum improves.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bearish to neutral on open interest, since puts slightly exceed calls. The zero put-call volume ratio reflects very light current trading activity, so the signal is not strong. Implied volatility is extremely high at 758.55 with IV percentile at 100 and IV rank above 100, showing options are pricing in very large expected movement, but this does not by itself make the stock an attractive long-term buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • Short-term momentum is constructive based on the positive and expanding MACD histogram. The stock also has a technical setup near a resistance breakout area, which could support a modest move higher if buying continues.

Neutral/Negative Catalysts

  • No news in the recent week means there is no clear event-driven catalyst. AI Stock Picker shows no signal and SwingMax also shows no recent signal. Hedge funds are neutral and insiders are neutral, so there is no notable institutional or insider accumulation. Similar-pattern trend data suggests only slight near-term upside and a negative one-month expectation. The company financial snapshot was unavailable, which limits confidence in long-term fundamentals.

Financial Performance

Latest quarter financials were not available due to a data error, so there is no reliable quarterly revenue or earnings trend to assess. Because the latest quarter season is missing, the fundamental growth picture cannot be confirmed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so Wall Street consensus cannot be directly measured. Based on the available evidence, the pros view would be limited to technical momentum and possible short-term upside, while the cons view is stronger: no news, no proprietary buy signal, neutral insider and hedge fund activity, and missing financial support. That makes the Wall Street case cautious rather than bullish.

Wall Street analysts forecast KRMD stock price to rise
5 Analyst Rating
Wall Street analysts forecast KRMD stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 4.590
sliders
Low
4
Averages
6.25
High
8
Current: 4.590
sliders
Low
4
Averages
6.25
High
8
B. Riley
B. Riley
Buy
maintain
$7 -> $8
AI Analysis
2026-03-13
Reason
B. Riley
B. Riley
Price Target
$7 -> $8
AI Analysis
2026-03-13
maintain
Buy
Reason
B. Riley raised the firm's price target on Koru Medical to $8 from $7 and keeps a Buy rating on the shares. Following the Q4 earnings report, B. Riley is "encouraged" by the continued execution across all three of its strategic pillars, the analyst tells investors in a research note.
Lake Street
Buy
upgrade
$6 -> $8
2025-12-22
Reason
Lake Street
Price Target
$6 -> $8
2025-12-22
upgrade
Buy
Reason
Lake Street raised the firm's price target on Koru Medical to $8 from $6 and keeps a Buy rating on the shares. The firm, which thinks a 510K submission for the oncology indication prior to year-end is "a meaningful catalyst, expects 2026 to be another year of growth acceleration and improving leverage, supporting revenue upside and multiple expansion, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for KRMD
Unlock Now

People Also Watch